Associate Director, Translational Medicine Lead
South San Francisco, CA, United States23h ago
Key details
- Salary
- $142K–$214K/yr
- Location
- South San Francisco, CA, United States
- Work style
- Onsite
- Level
- Lead / Staff+
- Job type
- Full-time
- Experience
- 3–5 yrs
- Function
- Operations & Strategy
- Focus area
- other
- Posted
- 23h ago
Skills
About the role
Location is flexible Gaithersburg, MD or South San Francisco, CA
About AstraZeneca
AstraZeneca is a global, science-led, patient-focused biopharmaceutical company committed to the discovery, development, and commercialization of prescription medicines for some of the world's most serious diseases. Within Hematology R&D, we drive a combination-focused pipeline across immuno-oncology, tumor drivers and resistance, DNA damage response, antibody-drug conjugates, cell therapy, and epigenetics to address unmet needs in hematologic cancers. Our mission is to eliminate cancer as a cause of death.
Translational Medicine — Hematology
The Translational Medicine (TM) function transforms hematological cancer biology into actionable insights that guide therapeutic development and clinical decision-making. Embedded within the Hematology R&D division, TM is the single point of accountability for robust, scientifically driven biomarker strategies across all hematology programs — leukemia, lymphoma, and myeloma. The team collaborates closely with Preclinical Bioscience, Clinical Development, Clinical Operations, Clinical Pharmacology, and Precision Diagnostic Development to deliver fit-for-purpose assays, translational data packages, and patient selection strategies across the full development spectrum.
Role Summary
We are seeking a highly motivated Associate Director, Translational Medicine Lead to develop and lead hypothesis-driven biomarker strategies and translational science across our B-cell malignancy programs, spanning B-cell Acute Lymphoblastic Leukemia (B-ALL), B-cell Chronic Lymphocytic Leukemia (B-CLL), and Non-Hodgkin Lymphoma (NHL), including combination therapy studies. The role will translate disease biology and therapeutic mechanism into actionable plans for patient stratification/selection, target engagement, pharmacodynamic assessment, depth and durability of response, and mechanisms of resistance. This is a 100% Translational Medicine role supporting large molecules (T-cell engaging bispecifics, ADCs, monoclonal antibodies), small molecules, and cell-based therapies.
The Associate Director will be accountable for the translational strategy for assigned programs and clinical trials, representing the TM function within cross-functional program teams from preclinical stages through Phase 1/2 and, where required, into Phase 3. The successful candidate brings established knowledge of B-cell disease biology, demonstrated experience with T-cell engaging bispecifics and/or ADCs, and a track record of delivering biomarker strategies in hematology drug development.
Key Responsibilities
Translational Strategy & Delivery
- Develop and own translational science strategies for assigned B-cell malignancy programs — including B-ALL, B-CLL, and NHL — from preclinical stages through Phase 1/2 and Phase 3 clinical studies.
- Generate and integrate disease linkage data to support indication selection, patient stratification, and targeted population definition across monotherapy and combination therapy studies.
- Measure and interpret target engagement, pharmacodynamic (PD) biomarkers, and mechanism of action (MoA) data to inform dose selection and clinical decision-making across multiple concurrent programs or trials.
- Define and investigate mechanisms of resistance to B-cell targeted therapies across modalities using longitudinal and relapse clinical samples.
- Analyze B-cell tumor biology, cancer pathway interactions, and tumor microenvironment features in patient samples to guide rational drug combination strategies and inform combination trial design.
Biomarker & Assay Development
- Lead development and deployment of fit-for-purpose translational assays (flow cytometry, IHC/IF, molecular, MRD-adjacent panels) both internally and through external CRO/laboratory partners.
- Collaborate with Precision Diagnostics to ensure appropriate sample collection, traceability, and documentation; support CDx pathway discussions where warranted.
- Contribute translational and biomarker content for regulatory interactions and filings, including health authority briefing materials where appropriate.
Cross-functional Collaboration & Portfolio Influence
- Represent the TM function within program-level cross-functional teams (eGPT and equivalent), acting as a scientific partner to Clinical Development, Oncology Research, Clinical Operations, and Product Development, ensuring alignment with overall asset strategy, disease biology, and key clinical development milestones.
- Embed biomarker strategies and translational endpoints into clinical study protocols, sample collection manuals, statistical analysis plans, and data delivery cadences for hematology studies across Phase 1 through Phase 3.
- Contribute to translational strategy across the broader B-cell hematology portfolio, connecting insights from individual programs to inform indication expansion and combination hypotheses.
- Partner with preclinical discovery teams to ensure translational insights inform early compound selection and target validation decisions.
- Contribute to and ensure the quality of TM clinical study reports, data reviews, scientific presentations, and recommendations for program governance and Go/No-Go decisions.
Scientific Communication & External Presence
- Integrate translational findings across experiments and studies to build a coherent scientific narrative in support of program and portfolio decision-making.
- Communicate biomarker data clearly to internal stakeholders — including program governance forums and leadership teams — with emerging ability to describe strategic implications, risks, and data caveats.
- Contribute to scientific publications and conference presentations; represent AstraZeneca in external scientific forums in B-cell malignancy translational research.
Required Qualifications
Scientific Expertise
- Established knowledge of B-cell malignancy biology spanning leukemia (B-ALL, B-CLL) and lymphoma (NHL), including disease pathogenesis, standard-of-care landscape, and mechanisms of therapeutic resistance.
- In-depth understanding of immunology and the tumor microenvironment in B-cell cancers, with ability to apply this knowledge to translational strategy and biomarker design.
- Demonstrated experience with T-cell engaging bispecifics (e.g., CD3-targeting bispecifics, BiTEs) in an oncology/hematology development context — REQUIRED.
- Demonstrated experience with antibody-drug conjugates (ADCs) in a hematology or oncology development context — REQUIRED.
Drug Development & Biomarker Experience
- PhD in a relevant biological science (hematology-oncology, immunology, oncology, molecular biology, or related field); postdoctoral and/or industry experience required.
- 3-5 years experience contributing to early phase oncology clinical trials, including biomarker plan development, protocol input, and sample analysis; exposure to Phase 3 trial biomarker strategies a plus.
- Demonstrated expertise in biomarker technologies such as flow cytometry, immunohistochemistry, molecular profiling, NGS, ctDNA, MRD assessment, cytokine/immune profiling, and other omics-based approaches as relevant to hematologic cancers.
- Emerging understanding of the end-to-end clinical development process — from dose escalation through registration — and the strategic role of biomarkers at each stage.
- Ability to work independently and deliver translational programs with regular managerial support; demonstrates sound scientific judgment and prioritization without close oversight.
Collaboration, Communication & Organizational Skills
- Proven ability to operate effectively and demonstrate scientific leadership within cross-functional program teams in a matrixed pharma or biotech environment; understands the roles of Clinical, Ops, Project Management, and HBS Clinical functions in delivering translational work.
- Clearly presents and integrates scientific data across experiments to support a cohesive program narrative; able to articulate the implications of translational findings for Go/No-Go decisions with emerging clarity on risks and caveats.
- Excellent communication and presentation skills for internal stakeholders and emerging external scientific audiences; comfortable representing TM in cross-functional governance settings.
- Emerging awareness of broader AstraZeneca functions (Regulatory, Medical, Commercial) and how TM outputs interface with and inform those stakeholders.
Preferred Qualifications
- Experience with small molecule hematology therapeutics in B-cell malignancies (e.g., BTK inhibitors, BCL-2 inhibitors) and familiarity with combination treatment strategies.
- Exposure to cell therapy programs (CAR-T or other engineered cell therapies) in B-cell leukemia or lymphoma.
- Familiarity with Minimal Residual Disease (MRD) methodologies (flow cytometry and/or NGS-based) in leukemia or lymphoma clinical development.
- Experience integrating multi-omic biomarker data (flow cytometry, ctDNA, cytokine panels, transcriptomics) to support clinical decision-making across combination regimens.
- Familiarity with regulatory expectations for biomarker analytical validation and CDx development.
- Early experience mentoring junior scientists; interest in contributing to team capability development.
The annual base pay (or hourly rate of compensation) for this position ranges from $142,377.60 - $213,566.40 USD Annual. Our positions offer eligibility for various incentives—an opportunity to receive short-term incentive bonuses, equity-based awards for salaried roles and commissions for sales roles. Benefits offered include qualified retirement programs, paid time off (i.e., vacation, holiday, and leaves), as well as health, dental, and vision coverage in accordance with the terms of the applicable plans.
Why AstraZeneca?
At AstraZeneca, we are dedicated to being a Great Place to Work — a place where you are empowered to push the boundaries of science and make a real difference to patients living with B-cell malignancies. Our inclusive culture champions diversity, collaboration, and lifelong learning. Translational scientists work side-by-side with world-class clinicians, discovery researchers, and diagnostics experts to pioneer the future of oncology medicine.
Join us to help bring the next generation of B-cell therapies — T-cell engagers, ADCs, small molecules, and cell therapies — to the patients who need them most.
Date Posted
20-Nov-2026Closing Date
06-Dec-2026Our mission is to build an inclusive environment where equal employment opportunities are available to all applicants and employees. In furtherance of that mission, we welcome and consider applications from all qualified candidates, regardless of their protected characteristics. If you have a disability or special need that requires accommodation, please complete the corresponding section in the application form.
How well do you match this job?
Free account needed to apply or save. It takes a minute, and we'll bring you right back to this job.